Skip Navigation

Cardiovascular Research 1997 36(2):174-184; doi:10.1016/S0008-6363(97)00175-2
© 1997 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Smart, S. C
Right arrow Articles by Jones, L. R
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Smart, S. C
Right arrow Articles by Jones, L. R
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 1997, European Society of Cardiology

Injury to the Ca2+ ATPase of the sarcoplasmic reticulum in anesthetized dogs contributes to myocardial reperfusion injury

Steven C Smarta,*, Kiran B Sagara, Jo El Schultza, David C Warltiera and Larry R Jonesb

aDivision of Cardiovascular Medicine, Department of Medicine and the Department of Anesthesiology, Medical College of Wisconsin, Milwaukee, WI, 53226, USA
bThe Krannert Institute of Cardiology, Indiana University School of Medicine, Indianapolis, IN 46202, USA

* Corresponding author. Tel. (+1-414) 257-6697; Fax (+1-414) 2577291; E-mail: ssmart@post.its.mcw.edu

Objective: Sarcoplasmic reticulum dysfunction may contribute to calcium (Ca2+) overload during myocardial reperfusion. The aim of this study was to investigate its role in reperfusion injury. Methods: Open chest dogs undergoing 15 min of left anterior descending coronary artery occlusion and 3 h of reperfusion were randomized to intracoronary infusions of 0.9% saline, vehicle, or the Ca2+ channel antagonist, nifedipine (50 µg/min from 2 minutes before to 5 minutes after reperfusion). After each experiment, transmural myocardial biopsies were removed from ischemic/reperfused and nonischemic myocardium in the beating state and analyzed for (i) sarcoplasmic reticulum protein content (Ca2+ ATPase, phospholamban, and calsequestrin) by immunoblotting and (ii) Ca2+ uptake by sarcoplasmic reticulum vesicles with and without 300 micromolar ryanodine or the Ca2+ ATPase activator, antiphospholamban (2D12) antibody. Results: Contractile function did not recover in controls and vehicle-treated dogs after ischemia and reperfusion (mean systolic shortening, –2±2%), but completely recovered in nifedipine-treated dogs (17±2%, p = NS vs. baseline, p<0.01 vs. control). Ventricular fibrillation occurred in 50% of controls and vehicle dogs and 0% of nifedipine-treated dogs (p<0.01). Ca2+ uptake by the sarcoplasmic reticulum vesicles was severely reduced in ischemic/reperfused myocardium of controls and vehicle dogs (p<0.01 vs. nonischemic). Ryanodine and the 2D12 antibody improved, but did not reverse the low Ca2+ uptake. Protein content was similar in ischemic/reperfused and nonischemic myocardium. In contrast, Ca2+ uptake and the responses to ryanodine and 2D12 antibody were normal in ischemic/reperfused myocardium from nifedipine-treated dogs. Conclusion: Dysfunction of the sarcoplasmic reticulum Ca2+ ATPase pump correlates with reperfusion injury. Reactivation of Ca2+ channels at reperfusion contributed to Ca2+ pump dysfunction. Ca2+ pump injury may be a critical event in myocardial reperfusion injury.

KEYWORDS Nifedipine; Calcium channel antagonist; Myocardial ischemia; Calcium, intracellular concentration; Protein analysis; Stunning arrhythmias; Ventricular fibrillation; Reperfusion; Dog, anesthetized


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
R. Pilankatta, D. Lewis, C. M. Adams, and G. Inesi
High Yield Heterologous Expression of Wild-type and Mutant Cu+-ATPase (ATP7B, Wilson Disease Protein) for Functional Characterization of Catalytic Activity and Serine Residues Undergoing Copper-dependent Phosphorylation
J. Biol. Chem., August 7, 2009; 284(32): 21307 - 21316.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Z. Xu, M. V. Cohen, J. M. Downey, T. L. Vanden Hoek, and Z. Yao
Attenuation of oxidant stress during reoxygenation by AMP 579 in cardiomyocytes
Am J Physiol Heart Circ Physiol, December 1, 2001; 281(6): H2585 - H2589.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. M. Heerdt, J. W. Holmes, B. Cai, A. Barbone, J. D. Madigan, S. Reiken, D. L. Lee, M. C. Oz, A. R. Marks, and D. Burkhoff
Chronic Unloading by Left Ventricular Assist Device Reverses Contractile Dysfunction and Alters Gene Expression in End-Stage Heart Failure
Circulation, November 28, 2000; 102(22): 2713 - 2719.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
N. S. Dhalla, A. B. Elmoselhi, T. Hata, and N. Makino
Status of myocardial antioxidants in ischemia-reperfusion injury
Cardiovasc Res, August 18, 2000; 47(3): 446 - 456.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. A. Fallavollita, S. Jacob, R. F. Young, and J. M. Canty Jr.
Regional alterations in SR Ca2+-ATPase, phospholamban, and HSP-70 expression in chronic hibernating myocardium
Am J Physiol Heart Circ Physiol, October 1, 1999; 277(4): H1418 - H1428.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
S. A. Thomas, J. A. Fallavollita, T.-C. Lee, J. Feng, and J. M. Canty Jr
Absence of Troponin I Degradation or Altered Sarcoplasmic Reticulum Uptake Protein Expression After Reversible Ischemia in Swine
Circ. Res., September 3, 1999; 85(5): 446 - 456.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.